by Truveta staff | Sep 12, 2023 | News
Medical Components, Inc. and Truveta are partnering to advance the use of real-world data to improve clinical care for patients battling cancer and kidney disease who require advanced vascular access for treatment. Truveta delivers the most complete, timely, and clean...
by Truveta staff | Aug 9, 2023 | News
Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication adherence, and adverse events. Medication dispense data helps researchers understand patients’ actual use of medications. With...
by Terry Myerson, CEO | Aug 1, 2023 | News
It is so helpful to have a world view of the industry you participate in, a view that is long term coherent, and toward which everything eventually converges to. Over the course of my tech career, I came to appreciate a complex world view balancing the intersecting...
by Terry Myerson, CEO | Jun 20, 2023 | News
I can’t imagine our country without the FDA continuously assessing the safety and efficacy of medical products, or our government without the CDC monitoring and guiding public health choices. And yet, we all saw during the pandemic that there is a clear opportunity...
by Terry Myerson, CEO | May 30, 2023 | News
There is a growing global consensus that “we need to regulate AI”. The most commonly cited suggestion is that we create a new global government agency to issue licenses for developing large AI models. This suggestion is coming from brilliant people thinking...
by Truveta staff | May 17, 2023 | News
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously announced pioneers Pfizer, Boston Scientific Corporation, and Alpine Immune Sciences. We...
